Showing results (291-300 of 309) with videos related to

Sort By:
Pageof 31
The Journal of Infectious Diseases|July 1, 1996
Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working GroupL L Lewis, D Venzon, J Church, et al.
Medicine|June 9, 2000
Chronic granulomatous disease. Report on a national registry of 368 patientsJ A Winkelstein, M C Marino, R B Johnston, et al.
The Journal of Infectious Diseases|March 10, 2001
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudineS Jankelevich, B U Mueller, C L Mackall, et al.
Carcinogenesis|June 21, 2008
Renal cell carcinoma, occupational pesticide exposure and modification by glutathione S-transferase polymorphismsS Karami, P Boffetta, N Rothman, et al.
The Journal of Infectious Diseases|August 7, 1999
Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infectionS Sei, S L Sandelli, G Theofan, et al.
Pediatrics|July 4, 1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infectionB U Mueller, J Sleasman, R P Nelson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2019
Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancerM J Gunter, S Alhomoud, M Arnold, et al.
Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii|December 30, 2025
INDIVIDUAL THYROID DOSE ESTIMATES FOR THE GENOMIC STUDY OF FOLLICULAR CARCINOMAS AND ADENOMAS IN PARTICIPANTS OF THE CHORNOBYL TISSUE BANKS V Masiuk, M I Chepurny, V B Buderatska, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Carcinogenesis|November 2, 2010
GSTM1 null and NAT2 slow acetylation genotypes, smoking intensity and bladder cancer risk: results from the New England bladder cancer study and NAT2 meta-analysisL E Moore, D R Baris, J D Figueroa, et al.
Pageof 31